Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
0.1292
-0.0019 (-1.45%)
Oct 19, 2026, 1:04 PM EDT - Market open
Vivos Therapeutics Employees
Vivos Therapeutics had 270 employees as of March 31, 2026. The number of employees increased by 2 or 0.75% since the number was last reported on December 31, 2025. That makes Vivos Therapeutics the 24,637th largest employer in the world and 3,163rd in the United States.
Employees
270
Change
2
Growth
0.75%
Revenue / Employee
$77,415
Profits / Employee
-$94,281
Market Cap
2.60M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Mar 31, 2026 | 270 | 2 | 0.75% | 270 | 0 |
| Dec 31, 2025 | 268 | 159 | 145.87% | 268 | 0 |
| Dec 31, 2024 | 109 | -14 | -11.38% | 109 | 0 |
| Dec 31, 2023 | 123 | -40 | -24.54% | 114 | 9 |
| Dec 31, 2022 | 163 | -4 | -2.40% | 154 | 9 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| WORK Medical Technology Group LTD | 238 |
| VolitionRx | 57 |
| Beyond Air | 54 |
| INVO Fertility | 42 |
| Adagio Medical Holdings | 41 |
| Nuwellis | 38 |
| Tenon Medical | 26 |
| 20/20 Biolabs | 14 |
VVOS News
- 4 days ago - Vivos Therapeutics to acquire 11% stake in SOD Sciences for $12M in preferred - TheFly
- 4 days ago - Vivos Therapeutics Agrees to Acquire Minority Stake in SOD Sciences and 50% Interest in Proprietary Pseudohypoxia Test - GlobeNewsWire
- 20 days ago - Vivos Therapeutics reports progress in material cost reductions, revenue growth - TheFly
- 20 days ago - Vivos Therapeutics Reports Progress in Material Cost Reductions and Revenue Growth Initiatives - GlobeNewsWire
- 5 weeks ago - Vivos Therapeutics Announces Material Debt Reduction - GlobeNewsWire
- 6 weeks ago - Vivos Therapeutics to Present at the 2026 Moody Capital Solutions Disruptive Growth & Life Sciences Conference - Newsfile Corp
- 7 weeks ago - Vivos Therapeutics, SPCVA to launch regional sleep testing and treatment center - TheFly
- 7 weeks ago - Vivos Therapeutics and South Palm Cardiovascular Associates Sign Definitive Agreements to Launch Regional Sleep Testing and Treatment Center - GlobeNewsWire